$USAQ
QHSLab Inc Stock $usaq

$usaq Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031462 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$267.7K	$269.3K	$324.5K
YoY Change	-18.87%	-17.0%
Cost Of Revenue	$132.7K	$143.7K	$167.4K
YoY Change	-15.49%	-14.14%
Gross Profit	$135.0K	$125.6K	$157.1K
YoY Change	-21.94%	-20.04%
Gross Profit Margin	50.43%	46.64%	48.41%
Selling, General & Admin	$208.6K	$262.6K	$331.6K
YoY Change	-11.67%	-20.8%	398.96%
% of Gross Profit	154.47%	209.05%	211.06%
Research & Development	$54.12K	$48.41K	$19.61K
YoY Change	93.49%	146.84%	-2.68%
% of Gross Profit	40.08%	38.54%	12.48%
Depreciation & Amortization	$36.64K	$36.65K	$18.03K
YoY Change	103.22%	103.27%
% of Gross Profit	27.14%	29.18%	11.48%
Operating Expenses	$280.7K	$329.0K	$369.2K
YoY Change	-0.5%	-10.88%	326.33%
Operating Profit	-$145.7K	-$203.4K	-$212.1K
YoY Change	33.49%	-4.1%	144.93%
Interest Expense	-$70.50K	$106.7K	-$88.66K
YoY Change	-49.57%	-220.35%	1194.31%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$216.2K	-$310.1K	-$300.8K
YoY Change	-20.04%	3.11%	221.85%
Income Tax
% Of Pretax Income
Net Earnings	-$216.2K	-$310.1K	-$300.8K
YoY Change	-20.04%	3.11%	221.85%
Net Earnings / Revenue	-80.76%	-115.15%	-92.69%
Basic Earnings Per Share		-$0.03	-$0.03
Diluted Earnings Per Share	-$0.02	-$0.03	-$34.79K
COMMON SHARES
Basic Shares Outstanding	9.316M shares	9.066M shares	8.646M shares
Diluted Shares Outstanding		9.068M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$178.7K	$237.9K	$543.3K
YoY Change	-37.71%	-56.21%	1936.39%
Cash & Equivalents	$178.7K	$237.9K	$543.3K
Short-Term Investments
Other Short-Term Assets	$7.310K	$49.34K	$37.32K
YoY Change	-67.81%	32.21%	424.16%
Inventory	$51.84K	$97.96K	$101.2K
Prepaid Expenses
Receivables	$47.73K	$58.09K	$38.34K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$285.6K	$443.3K	$720.2K
YoY Change	-35.94%	-38.45%	2030.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$1.522M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.672M	$1.709M	$1.734M
YoY Change	-5.15%	-1.49%	10739.56%
TOTAL ASSETS
Total Short-Term Assets	$285.6K	$443.3K	$720.2K
Total Long-Term Assets	$1.672M	$1.709M	$1.734M
Total Assets	$1.957M	$2.152M	$2.455M
YoY Change	-11.37%	-12.33%	4828.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$85.74K	$150.0K	$87.56K
YoY Change	320.93%	71.31%	178.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$342.4K	$297.2K	$0.00
YoY Change	34.87%
Long-Term Debt Due	$342.4K	$297.2K	$776.9K
YoY Change	34.87%	-61.74%	1312.56%
Total Short-Term Liabilities	$1.707M	$1.657M	$879.3K
YoY Change	95.08%	88.4%	917.15%
LONG-TERM LIABILITIES
Long-Term Debt	$174.4K	$209.0K	$871.8K
YoY Change	-65.33%	-76.03%	93.31%
Other Long-Term Liabilities		$0.00	$118.8K
YoY Change		-100.0%	11.86%
Total Long-Term Liabilities	$174.4K	$209.0K	$990.7K
YoY Change	-65.77%	-78.9%	77.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.707M	$1.657M	$879.3K
Total Long-Term Liabilities	$174.4K	$209.0K	$990.7K
Total Liabilities	$1.881M	$1.866M	$1.870M
YoY Change	35.88%	-0.23%	190.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.515M	-$3.299M
YoY Change	39.54%
Common Stock	$932.00	$932.00
YoY Change	6.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$76.25K	$286.2K	$584.6K
YoY Change
Total Liabilities & Shareholders Equity	$1.957M	$2.152M	$2.455M
YoY Change	-11.37%	-12.33%	4828.8%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$216.2K	-$310.1K	-$300.8K
YoY Change	-20.04%	3.11%	221.85%
Depreciation, Depletion And Amortization	$36.64K	$36.65K	$18.03K
YoY Change	103.22%	103.27%
Cash From Operating Activities	-$69.78K	-$183.1K	-$136.7K
YoY Change	-41.17%	33.91%	127.96%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$43.18K
YoY Change	-100.0%	-100.0%	169.87%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$43.18K
YoY Change	-100.0%	-100.0%	169.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.55K	323.9K	577.3K
YoY Change	-111.54%	-43.9%	464.4%
NET CHANGE
Cash From Operating Activities	-69.78K	-183.1K	-136.7K
Cash From Investing Activities	0.000	0.000	-43.18K
Cash From Financing Activities	10.55K	323.9K	577.3K
Net Change In Cash	-59.23K	140.8K	397.4K
YoY Change	-76.9%	-64.58%	1410.87%
FREE CASH FLOW
Cash From Operating Activities	-$69.78K	-$183.1K	-$136.7K
Capital Expenditures	$0.00	$0.00	-$43.18K
Free Cash Flow	-$69.78K	-$183.1K	-$93.55K
YoY Change	-3.37%	95.72%	112.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Deferred Compensation Equity DeferredCompensationEquity		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000856984
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	USAQ	Accrued Interest Expenses Non Current AccruedInterestExpensesNonCurrent		usd
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	149995	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22713	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	443322	usd
	USAQ	Common Stock Issued For Debt Issuance Costs CommonStockIssuedForDebtIssuanceCosts		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19041
	dei	Entity Registrant Name EntityRegistrantName	QHSLab, Inc
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-1104301
	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Northpoint Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 302
	dei	Entity Address Address Line3 EntityAddressAddressLine3	West Palm
	dei	Entity Address City Or Town EntityAddressCityOrTown	Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33407
	dei	City Area Code CityAreaCode	(929)
	dei	Local Phone Number LocalPhoneNumber	379-6503
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 Par Value
	dei	Trading Symbol TradingSymbol	USAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9315508	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237934	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286855	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58094	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	97959	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	65740	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49335	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	445782	usd
CY2022Q3	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186159	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1522360	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1576444	usd
CY2022Q3	us-gaap	Assets Assets	2151841	usd
CY2021Q4	us-gaap	Assets Assets	2208497	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20370	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	85612	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58615	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	297225	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	253865	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1123811	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1656643	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	874954	usd
CY2021Q4	USAQ	Accrued Interest Expenses Non Current AccruedInterestExpensesNonCurrent	6521	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	208999	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	402956	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	208999	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	509477	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1865642	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1384431	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9315508	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9315508	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8756093	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8756093	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	932	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	876	usd
CY2021Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	6968	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3583594	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3348681	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3298699	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2518895	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	286199	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2151841	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2208497	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	269323	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	324479	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	975469	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1084436	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	143716	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	167393	usd
	us-gaap	Cost Of Revenue CostOfRevenue	490965	usd
	us-gaap	Cost Of Revenue CostOfRevenue	586651	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	125607	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	157086	usd
	us-gaap	Gross Profit GrossProfit	484504	usd
	us-gaap	Gross Profit GrossProfit	497785	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	154620	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	181820	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	387687	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	455128	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107965	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	149741	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	321573	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	354831	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48405	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19609	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	135998	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62901	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18028	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18028	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54084	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18028	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	329018	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	369198	usd
	us-gaap	Operating Expenses OperatingExpenses	899342	usd
	us-gaap	Operating Expenses OperatingExpenses	890888	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-203411	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-212112	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-414838	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-393103	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	106704	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	88658	usd
	us-gaap	Interest Expense InterestExpense	362946	usd
	us-gaap	Interest Expense InterestExpense	106680	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-310115	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-300770	usd
	us-gaap	Net Income Loss NetIncomeLoss	-779804	usd
	us-gaap	Net Income Loss NetIncomeLoss	-499783	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9068225	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8646399	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8889836	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7570228	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3484	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	27925	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2020	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8920	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-190304	usd
CY2021Q3	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	20073	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8921	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	30000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-300770	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	584546	usd
	us-gaap	Net Income Loss NetIncomeLoss	-779804	usd
	us-gaap	Net Income Loss NetIncomeLoss	-499783	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9173	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	676111	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3484	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8921	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-279385	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	409131	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	50000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	81183	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	6000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-310115	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	286199	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-608326	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	581	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	194211	usd
CY2021Q1	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	67812	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8920	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-86686	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-423488	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	20850	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	132075	usd
CY2021Q2	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	36594	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8921	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	862500	usd
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-112327	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	555125	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	49418	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	221779	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	91315	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18028	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	267889	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	54881	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	23842	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26762	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6968	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	195328	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3207	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22184	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	87735	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	85000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	269403	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	793265	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48921	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	448969	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	286855	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94342	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	237934	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	543311	usd
	us-gaap	Interest Paid Net InterestPaidNet	55939	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32219	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1535	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	26622	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25723	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	129625	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-56808	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-15717	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	39118	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	30535	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-281205	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-236131	usd
	us-gaap	Payments For Software PaymentsForSoftware	37119	usd
	us-gaap	Payments For Software PaymentsForSoftware	108165	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37119	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108165	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	400000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	850000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	128500	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	86000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	279097	usd
	us-gaap	Interest Paid Net InterestPaidNet	21265	usd
	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	77925	usd
	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	326286	usd
	us-gaap	Stock Issued1 StockIssued1	1612500	usd
	USAQ	Common Stock Issued For Debt Issuance Costs CommonStockIssuedForDebtIssuanceCosts	30000	usd
	USAQ	Warrants Issued In Conjunction With Convertible Note Payable WarrantsIssuedInConjunctionWithConvertibleNotePayable	81183	usd
	USAQ	Warrants Issued In Conjunction With Convertible Note Payable WarrantsIssuedInConjunctionWithConvertibleNotePayable	221779	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zNt43MDdy9zg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_82B_zoa98jUkev6i">The Company</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QHSLab, Inc. (f/k/a USA Equities Corp.) (the “Company”, or the “Registrant”) was incorporated in Delaware on September 1, 1983<span style="background-color: white">. </span>In 2015, the Company changed its name to USA Equities Corp and created a wholly-owned subsidiary for future operations (“USAQ Corporation, Inc.”). In 2019, the Company consummated a share exchange agreement with the stockholders of Medical Practice Income, Inc. a Florida corporation (“MPI”). As a result of the acquisition, MPI became a wholly-owned subsidiary of the Company and the Company became engaged in value-based healthcare, informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. On September 23, 2021, the Company changed its state of incorporation from Delaware to Nevada as a result of a merger with and into its newly formed wholly-owned subsidiary, USA Equities Corp., a Nevada corporation (“USA Equities Nevada”), the surviving entity pursuant to an Agreement and Plan of Merger. USA Equities Nevada is deemed to be the successor to USA Equities Corp, the Delaware corporation. <span style="background-color: white">On April 19, 2022, the Company changed its name to QHSLab, Inc.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a medical device technology and software-as-a-service (“SaaS”) company focused on enabling primary care physicians (“PCP’s”) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zNIeqVAAq7M7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zt9r4IZ3T3Hk">Use of Estimates</span>:</i> The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q3	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186159	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	37231	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2022Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	37231	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	135998	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62901	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3298699	usd
	USAQ	Net Operating Losses Carryforwards Expire Date NetOperatingLossesCarryforwardsExpireDate	begin to expire in 2027
CY2022Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	223390	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	186271	usd
	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	67267	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	70474	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9173	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58094	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	186159	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	186271	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	90140	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36056	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1522360	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1576444	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	37231	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1123811	usd
CY2021Q2	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1612500	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54084	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18028	usd
CY2022Q3	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	467807	usd
CY2021Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	644158	usd
CY2022Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	128500	usd
CY2022Q1	us-gaap	Payments For Loans PaymentsForLoans	16305	usd
CY2022Q3	us-gaap	Loans Payable LoansPayable	41768	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	16793	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1246000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	881000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	122189	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	238896	usd
CY2022Q3	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	1123811	usd
CY2021Q4	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	642104	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2676647	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2119793	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	23842	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26762	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6968	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	195328	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1100000	shares
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0021	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.763	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure

Files In Submission

Name	View Source	Status
usaq-20220930_cal.xml	Edgar Link	unprocessable
0001493152-22-031462-index-headers.html	Edgar Link	pending
0001493152-22-031462-index.html	Edgar Link	pending
0001493152-22-031462.txt	Edgar Link	pending
0001493152-22-031462-xbrl.zip	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usaq-20220930.xsd	Edgar Link	pending
usaq-20220930_def.xml	Edgar Link	unprocessable
usaq-20220930_lab.xml	Edgar Link	unprocessable
usaq-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USAQ
QHSLab Inc Stock $usaq

2022 Q4 Form 10-Q Financial Statement

#000149315222031462 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ QHSLab Inc Stock $usaq

2022 Q4 Form 10-Q Financial Statement

#000149315222031462 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ
QHSLab Inc Stock $usaq